JOHNSON & JOHNSON Long-Term Concentrated

Location: New Brunswick, NJ

CIK: 0000200406 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 10, 2022

Total Value: $340M (100.0% shares, 0.0% debt)

Holdings (22)

FATE Fate Therapeutics, Inc. 22.3%
Value $75.72M Shares 3,379,064 Share Price $22.41 Est. Cost/Share $78.44 Unrealized @ Report Date -71.4%
LEGN Legend Biotech Corporation 19.6%
Value $66.47M Shares 1,629,173 Share Price $40.80 Est. Cost/Share $41.61 Unrealized @ Report Date -2.0%
PRCT Procept BioRobotics Corporation 10.5%
Value $35.82M Shares 863,908 Share Price $41.46 Est. Cost/Share $38.38 Unrealized @ Report Date +8.0%
CVRX CVRx, Inc. 9.6%
Value $32.61M Shares 3,495,575 Share Price $9.33 Est. Cost/Share $19.18 Unrealized @ Report Date -51.4%
MGTX MeiraGTx Holdings plc 7.2%
Value $24.38M Shares 2,898,550 Share Price $8.41 Est. Cost/Share $13.69 Unrealized @ Report Date -38.6%
PTGX Protagonist Therapeutics Inc. 6.1%
Value $20.65M Shares 2,449,183 Share Price $8.43 Est. Cost/Share $42.63 Unrealized @ Report Date -80.2%
XNCR Xencor, Inc. 5.7%
Value $19.43M Shares 748,062 Share Price $25.98 Est. Cost/Share $37.91 Unrealized @ Report Date -31.5%
HLTHQ Cue Health, Inc. 4.9%
Value $16.7M Shares 5,548,864 Share Price $3.01 Est. Cost/Share $11.81 Unrealized @ Report Date —
— Fusion Pharmaceuticals Inc. 3.3%
Value $11.05M Shares 3,670,516 Share Price $3.01 Est. Cost/Share $7.92 Unrealized @ Report Date —
— Adicet Bio, Inc. 3.1%
Value $10.37M Shares 728,944 Share Price $14.22 Est. Cost/Share $7.84 Unrealized @ Report Date —
ARWR Arrowhead Pharmaceuticals, Inc. 2.4%
Value $8.183M Shares 247,598 Share Price $33.05 Est. Cost/Share $64.75 Unrealized @ Report Date -49.0%
— Point Biopharma Global Inc. 2.3%
Value $7.73M Shares 1,000,000 Share Price $7.73 Est. Cost/Share $7.69 Unrealized @ Report Date —
— Vor Biopharma, Inc. 1.3%
Value $4.277M Shares 1,074,658 Share Price $3.98 Est. Cost/Share $15.68 Unrealized @ Report Date —
NNOX Nano-X Imaging Ltd. 0.6%
Value $2.207M Shares 192,429 Share Price $11.47 Est. Cost/Share $20.72 Unrealized @ Report Date -44.6%
ALDX Aldeyra Therapeutics, Inc. 0.6%
Value $2.108M Shares 394,834 Share Price $5.34 Est. Cost/Share $9.18 Unrealized @ Report Date -41.8%
— SomaLogic, Inc. 0.2%
Value $815K Shares 281,052 Share Price $2.90 Est. Cost/Share $12.39 Unrealized @ Report Date —
— BiomX Inc. 0.2%
Value $725K Shares 2,133,402 Share Price $0.34 Est. Cost/Share $3.06 Unrealized @ Report Date —
— PhaseBio Pharmaceuticals, Inc. 0.1%
Value $283K Shares 1,607,044 Share Price $0.18 Est. Cost/Share $3.11 Unrealized @ Report Date —
— Tracon Pharmaceuticals, Inc. 0.0%
Value $140K Shares 84,003 Share Price $1.67 Est. Cost/Share $3.87 Unrealized @ Report Date —
— Senseonics Holdings, Inc. 0.0%
Value $72,000 Shares 54,621 Share Price $1.32 Est. Cost/Share $3.39 Unrealized @ Report Date —
— Graybug Vision, Inc. 0.0%
Value $47,000 Shares 49,547 Share Price $0.95 Est. Cost/Share $3.31 Unrealized @ Report Date —
— Catalyst Biosciences, Inc. 0.0%
Value $34,000 Shares 66,951 Share Price $0.51 Est. Cost/Share $4.11 Unrealized @ Report Date —